Inactive Instrument

Analyst Reco. RXi Pharmaceuticals Corp Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 22	Phio Pharmaceuticals Corp. Presents New Data About Its Lead Clinical Product Candidate, PH-762	CI
Apr. 16	Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology	CI

HC Wainwright Adjusts Price Target on Phio Pharmaceuticals to $4 From $6, Keeps Buy Rating	Feb. 06	MT
PHIO PHARMACEUTICALS : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target to $6 From $4, Keeps Buy Rating	21-06-14	MT

No results for this search